Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:37:49.107Z.
Calculation as of: 2026-10-06T15:37:49.107Z.
Quote observation: 2026-10-06T15:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1bedec3c82b29a146d7673ff9ad1d122c49f5fbab6a9d52b7884226ded119d4d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
3.28x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.89B
EV/EBITDA Ratio
170.26x
TTM Avg
162.32x
3Y Avg
213.45x
5Y Avg
213.45x
Market Cap
$1.86B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.90B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.84B
EV/EBITDA Ratio
13.50x
TTM Avg
17.09x
3Y Avg
17.06x
5Y Avg
16.05x
Market Cap
$1.83B
EV/EBITDA Ratio
N/A
TTM Avg
2603.44x
3Y Avg
1662.57x
5Y Avg
1662.57x
Market Cap
$1.82B
EV/EBITDA Ratio
21.82x
TTM Avg
30.23x
3Y Avg
32.57x
5Y Avg
30.28x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.87B | N/A | 3.28x | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.87B | 50.79x | 24.79x | 97.87x | 107.08x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 170.26x | 162.32x | 213.45x | 213.45x |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | N/A | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.85B | N/A | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 13.50x | 17.09x | 17.06x | 16.05x |
| Novocure Ltd (NVCR)vs › | $1.83B | N/A | 2603.44x | 1662.57x | 1662.57x |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 21.82x | 30.23x | 32.57x | 30.28x |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-05-06 | 3.31x |
| 2026-05-05 | 2.87x |
| 2026-05-04 | 2.84x |
| 2026-05-01 | 2.85x |
| 2026-04-30 | 2.81x |
| 2026-04-29 | 2.82x |
| 2026-04-28 | 2.80x |
| 2026-04-27 | 2.86x |
| 2026-04-24 | 2.91x |
| 2026-04-23 | 2.89x |
| 2026-04-22 | 2.99x |
| 2026-04-21 | 3.00x |
| 2026-04-20 | 3.07x |
| 2026-04-17 | 3.13x |
| 2026-04-16 | 3.06x |
| 2026-04-15 | 3.08x |
| 2026-04-14 | 2.97x |
| 2026-04-13 | 2.87x |
| 2026-04-10 | 2.87x |
| 2026-04-09 | 3.02x |
| 2026-04-08 | 2.98x |
| 2026-04-07 | 2.83x |
| 2026-04-06 | 2.82x |
| 2026-04-02 | 2.73x |
| 2026-04-01 | 2.84x |
| 2026-03-31 | 2.88x |
| 2026-03-30 | 2.86x |
| 2026-03-27 | 2.99x |
| 2026-03-26 | 3.17x |
| 2026-03-25 | 3.30x |
| 2026-03-24 | 3.28x |
| 2026-03-23 | 3.44x |
| 2026-03-20 | 3.40x |
| 2026-03-19 | 3.44x |
| 2026-03-18 | 3.54x |
| 2026-03-17 | 3.76x |
| 2026-03-16 | 3.56x |
| 2026-03-13 | 3.62x |
| 2026-03-12 | 3.64x |
| 2026-03-11 | 3.82x |
| 2026-03-10 | 3.78x |
| 2026-03-09 | 3.73x |
| 2026-03-06 | 3.53x |
| 2026-03-05 | 3.53x |
| 2026-03-04 | 3.50x |
| 2026-03-03 | 3.36x |
| 2026-03-02 | 3.58x |
| 2026-02-27 | 3.59x |
| 2026-02-26 | 5.19x |
| 2026-02-25 | 4.41x |
| 2026-02-24 | 4.38x |
| 2026-02-23 | 4.33x |
| 2026-02-20 | 4.25x |
| 2026-02-19 | 4.27x |
| 2026-02-18 | 4.02x |
| 2026-02-17 | 4.00x |
| 2026-02-13 | 4.02x |
| 2026-02-12 | 3.89x |
| 2026-02-11 | 4.15x |
| 2026-02-10 | 4.04x |
| 2026-02-09 | 4.02x |
| 2026-02-06 | 3.81x |
| 2026-02-05 | 3.63x |
| 2026-02-04 | 3.82x |
| 2026-02-03 | 3.87x |
| 2026-02-02 | 4.02x |
| 2026-01-30 | 4.09x |
| 2026-01-29 | 4.37x |
| 2026-01-28 | 4.27x |
| 2026-01-27 | 4.54x |
| 2026-01-26 | 4.46x |
| 2026-01-23 | 4.24x |
| 2026-01-22 | 4.51x |
| 2026-01-21 | 4.58x |
| 2026-01-20 | 3.79x |
| 2026-01-16 | 3.70x |
| 2026-01-15 | 3.59x |
| 2026-01-14 | 3.78x |
| 2026-01-13 | 4.01x |
| 2026-01-12 | 3.58x |
| 2026-01-09 | 3.35x |
| 2026-01-08 | 3.38x |
| 2026-01-07 | 3.52x |
| 2026-01-06 | 3.43x |
| 2026-01-05 | 3.34x |
| 2026-01-02 | 3.29x |
| 2025-12-31 | 3.09x |
| 2025-12-30 | 3.09x |
| 2025-12-29 | 3.14x |
| 2025-12-26 | 3.15x |
| 2025-12-24 | 3.20x |
| 2025-12-23 | 3.13x |
| 2025-12-22 | 3.17x |
| 2025-12-19 | 3.07x |
| 2025-12-18 | 3.08x |
| 2025-12-17 | 3.01x |
| 2025-12-16 | 3.01x |
| 2025-12-15 | 3.03x |
| 2025-12-12 | 3.02x |
| 2025-12-11 | 3.08x |
| 2025-12-10 | 3.10x |
| 2025-12-09 | 3.07x |
| 2025-12-08 | 3.12x |
| 2025-12-05 | 3.18x |
| 2025-12-04 | 3.16x |
| 2025-12-03 | 3.15x |
| 2025-12-02 | 3.04x |
| 2025-12-01 | 3.08x |
| 2025-11-28 | 3.25x |
| 2025-11-26 | 3.20x |
| 2025-11-25 | 3.08x |
| 2025-11-24 | 3.05x |
| 2025-11-21 | 2.98x |
| 2025-11-20 | 2.86x |
| 2025-11-19 | 2.92x |
| 2025-11-18 | 3.02x |
| 2025-11-17 | 3.13x |
| 2025-11-14 | 3.21x |
| 2025-11-13 | 3.25x |
| 2025-11-12 | 3.32x |
| 2025-11-11 | 3.43x |
| 2025-11-10 | 3.28x |
| 2025-11-07 | 3.43x |
| 2025-11-06 | 3.32x |
| 2025-11-05 | 3.37x |
| 2025-11-04 | 3.29x |
| 2025-11-03 | 3.47x |
| 2025-10-31 | 3.68x |
| 2025-10-30 | 3.70x |
| 2025-10-29 | 3.68x |
| 2025-10-28 | 3.74x |
| 2025-10-27 | 3.82x |
| 2025-10-24 | 3.74x |
| 2025-10-23 | 3.67x |
| 2025-10-22 | 3.71x |
| 2025-10-21 | 3.77x |
| 2025-10-20 | 3.86x |
| 2025-10-17 | 3.55x |
| 2025-10-16 | 3.72x |
| 2025-10-15 | 3.91x |
| 2025-10-14 | 3.90x |
| 2025-10-13 | 3.78x |
| 2025-10-10 | 3.65x |
| 2025-10-09 | 3.77x |
| 2025-10-08 | 3.91x |
| 2025-10-07 | 4.05x |
| 2025-10-06 | 3.99x |
| 2025-10-03 | 4.16x |
| 2025-10-02 | 4.20x |
| 2025-10-01 | 4.17x |
| 2025-09-30 | 3.80x |
| 2025-09-29 | 3.76x |
| 2025-09-26 | 3.75x |
| 2025-09-25 | 3.66x |
| 2025-09-24 | 3.79x |
| 2025-09-23 | 3.80x |
| 2025-09-22 | 3.89x |
| 2025-09-19 | 3.82x |
| 2025-09-18 | 3.74x |
| 2025-09-17 | 3.68x |
| 2025-09-16 | 3.76x |
| 2025-09-15 | 3.54x |
| 2025-09-12 | 3.50x |
| 2025-09-11 | 3.63x |
| 2025-09-10 | 3.49x |
| 2025-09-09 | 3.49x |
| 2025-09-08 | 3.39x |
| 2025-09-05 | 3.46x |
| 2025-09-04 | 3.41x |
| 2025-09-03 | 3.24x |
| 2025-09-02 | 3.30x |
| 2025-08-29 | 3.27x |
| 2025-08-28 | 3.32x |
| 2025-08-27 | 3.32x |
| 2025-08-26 | 3.28x |
| 2025-08-25 | 3.29x |
| 2025-08-22 | 3.43x |
| 2025-08-21 | 3.34x |
| 2025-08-20 | 3.84x |
| 2025-08-19 | 4.18x |
| 2025-08-18 | 4.27x |
| 2025-08-15 | 4.21x |
| 2025-08-14 | 4.14x |
| 2025-08-13 | 3.88x |
| 2025-08-12 | 3.72x |
| 2025-08-11 | 3.52x |
| 2025-08-08 | 3.67x |
| 2025-08-07 | 3.85x |
| 2025-08-06 | 2.88x |
| 2025-08-05 | 2.54x |
| 2025-08-04 | 2.55x |
| 2025-08-01 | 2.48x |
| 2025-07-31 | 2.51x |
| 2025-07-30 | 2.59x |
| 2025-07-29 | 2.65x |
| 2025-07-28 | 2.76x |
| 2025-07-25 | 2.83x |
| 2025-07-24 | 2.90x |
| 2025-07-23 | 2.98x |
| 2025-07-22 | 2.74x |
| 2025-07-21 | 2.72x |
| 2025-07-18 | 2.65x |
| 2025-07-17 | 2.65x |
| 2025-07-16 | 2.63x |
| 2025-07-15 | 2.60x |
| 2025-07-14 | 2.64x |
| 2025-07-11 | 2.59x |
| 2025-07-10 | 2.69x |
| 2025-07-09 | 2.67x |
| 2025-07-08 | 2.67x |
| 2025-07-07 | 2.50x |
| 2025-07-03 | 2.57x |
| 2025-07-02 | 2.56x |
| 2025-07-01 | 2.50x |
| 2025-06-30 | 2.38x |
| 2025-06-27 | 2.40x |
| 2025-06-26 | 2.46x |
| 2025-06-25 | 2.45x |
| 2025-06-24 | 2.45x |
| 2025-06-23 | 2.38x |
| 2025-06-20 | 2.42x |
| 2025-06-18 | 2.38x |
| 2025-06-17 | 2.45x |
| 2025-06-16 | 2.66x |
| 2025-06-13 | 2.63x |
| 2025-06-12 | 2.71x |
| 2025-06-11 | 2.69x |
| 2025-06-10 | 2.73x |
| 2025-06-09 | 2.81x |
| 2025-06-06 | 2.83x |
| 2025-06-05 | 2.65x |
| 2025-06-04 | 2.71x |
| 2025-06-03 | 2.75x |
| 2025-06-02 | 2.68x |
| 2025-05-30 | 2.78x |
| 2025-05-29 | 2.72x |
| 2025-05-28 | 2.62x |
| 2025-05-27 | 2.80x |
| 2025-05-23 | 2.75x |
| 2025-05-22 | 2.76x |
| 2025-05-21 | 2.69x |
| 2025-05-20 | 2.91x |
| 2025-05-19 | 2.94x |
| 2025-05-16 | 2.54x |
| 2025-05-15 | 2.37x |
| 2025-05-14 | 2.25x |
| 2025-05-13 | 2.33x |
| 2025-05-12 | 2.39x |
| 2025-05-09 | 2.25x |
